Incyte’s vision is to become a leading biopharmaceutical company by building a proprietary pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology.
Incyte’s vision is to become a leading biopharmaceutical company by building a proprietary pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology.
⚠ No related posts found.
Sign-up for the Weekly Newsletter from North New Castle News.